LGND Operating Cash Flow (Statement)

Ligand Pharmaceuticals Inc · Operating Cash Flow (Statement)

LGND logo

LGND Operating Cash Flow (Statement)

Latest reported$24.02M
LGND Quarterly Cash from Operations (-$2.80M → $24.02M)
High-resolution chart · PNG

LGND operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
24,018,000
48,691,000
45,844,000
13,090,000
15,797,000
-25,516,000
28,471,000
36,530,000
13,314,000
18,691,000
7,116,000
7,646,000
-82,000
33,948,000
53,472,000
20,489,000
11,878,000
52,011,000
27,642,000
20,025,000
20,377,000
10,754,000
537,000
12,745,000
24,382,000
16,922,000
-7,339,000
-6,197,000
-61,058,000
45,258,000
32,572,000
27,082,000
73,644,000
60,761,000
31,310,000
27,650,000
10,386,000
24,222,000
20,993,000
18,523,000
10,371,000
13,114,000
13,665,000
10,437,000
10,046,000
7,579,000
10,246,000
3,735,000
4,008,000
2,577,000
12,034,000
-359,000
6,937,000
2,078,000
2,172,000
-910,000
-732,000
-369,000
7,017,000
-1,055,000
-8,045,000
911,000
-1,300,000
-7,674,000
-2,217,000
-15,876,000
-1,289,000
-11,341,000
2,950,000
-24,121,000
6,193,000
-13,448,000
-3,971,000
-9,399,000
-8,787,000
-14,231,000
-29,360,000
-45,349,000
-84,069,000
-28,021,000
-6,447,000
-19,984,000
12,072,000
6,795,000
-7,905,000
-2,597,000
28,040,000
-7,034,000
-11,636,000
-3,616,000
9,176,000
-2,611,000
3,456,000
-9,747,000
-9,562,000
-3,526,000
-11,883,000
-141,000
-3,471,000
-6,956,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.